Browsing: Next

Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historically associated with bariatric surgery and potentially giving Lilly another major product after the success of Mounjaro

NEW YORK, Aug. 20, 2026 /PRNewswire/ — Crunch Fitness, one of the world’s fastest-growing and most innovative fitness brands, today announced the next evolution of Crunch Select, the company’s premium franchise concept that delivers an elevated Crunch experience to new markets. The reimagined concept features boutique-inspired studios, enhanced recovery experiences, top-tier amenities, and refined finishes,…

As the Redwood Region RISE initiative concludes, our region stands at a crossroads for healthcare and economic development. I was fortunate to have the opportunity to serve on the Leadership Team for the Redwood Region RISE economic development initiative over the better part of the last two years. The experience deepened my understanding of economic…

The Neurofibromatosis and Schwannomatosis Patient and Family Symposium will be held virtually Saturday, Aug. 22, from 9 a.m. to noon. The symposium is free and open to people affected by neurofibromatosis and schwannomatosis, as well as their families, loved ones and caregivers